Search research articles
Contact Us
Filters
Showing results (631-640 of 818) with videos related to
Page
of 82
Sort By:
The Journal of Antimicrobial Chemotherapy
|
May 29, 2000
Anti-gonococcal activity of gemifloxacin against fluoroquinolone-resistant strains and a comparison of agar dilution and Etest methods
R N Jones, L M Deshpande, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease
|
November 1, 2001
Neisseria meningitidis with decreased susceptibility to penicillin: report from the SENTRY antimicrobial surveillance program, North America, 1998-99
S S Richter, K A Gordon, P R Rhomberg, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2002
In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp
M A Pfaller, S A Messer, R J Hollis, et al.
Antimicrobial Agents and Chemotherapy
|
June 1, 1985
In vitro comparative antimicrobial activity of cefpimizole against clinical isolates from five medical centers
R N Jones, L W Ayers, T L Gavan, et al.
Diagnostic Microbiology and Infectious Disease
|
December 24, 1997
Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study Group
C H Ballow, R N Jones, D M Johnson, et al.
Journal of Clinical Microbiology
|
August 1, 1982
Collaborative evaluation of the micro-media systems anaerobe susceptibility panel: comparisons with reference methods and test reproducibility
R N Jones, A L Barry, J L Cotton, et al.
Diagnostic Microbiology and Infectious Disease
|
February 12, 1998
Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group
M A Pfaller, R N Jones, S A Marshall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 6, 2000
Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility
H Wisplinghoff, M B Edmond, M A Pfaller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 26, 2001
Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999)
A C Gales, R N Jones, K R Forward, et al.
The Journal of Antibiotics
|
January 1, 1979
Piperacillin (T-1220), a new semisynthetic penicillin. II. In vitro antimicrobial activity and synergy comparison with carbenicillin and gentamicin
R N Jones, R R Packer, A L Barry, et al.
Page
of 82
Search research articles
Search
Showing results (631-640 of 818) with videos related to
Sort By:
Page
of 82
The Journal of Antimicrobial Chemotherapy
|
May 29, 2000
Anti-gonococcal activity of gemifloxacin against fluoroquinolone-resistant strains and a comparison of agar dilution and Etest methods
R N Jones, L M Deshpande, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease
|
November 1, 2001
Neisseria meningitidis with decreased susceptibility to penicillin: report from the SENTRY antimicrobial surveillance program, North America, 1998-99
S S Richter, K A Gordon, P R Rhomberg, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2002
In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp
M A Pfaller, S A Messer, R J Hollis, et al.
Antimicrobial Agents and Chemotherapy
|
June 1, 1985
In vitro comparative antimicrobial activity of cefpimizole against clinical isolates from five medical centers
R N Jones, L W Ayers, T L Gavan, et al.
Diagnostic Microbiology and Infectious Disease
|
December 24, 1997
Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study Group
C H Ballow, R N Jones, D M Johnson, et al.
Journal of Clinical Microbiology
|
August 1, 1982
Collaborative evaluation of the micro-media systems anaerobe susceptibility panel: comparisons with reference methods and test reproducibility
R N Jones, A L Barry, J L Cotton, et al.
Diagnostic Microbiology and Infectious Disease
|
February 12, 1998
Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group
M A Pfaller, R N Jones, S A Marshall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 6, 2000
Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility
H Wisplinghoff, M B Edmond, M A Pfaller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 26, 2001
Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999)
A C Gales, R N Jones, K R Forward, et al.
The Journal of Antibiotics
|
January 1, 1979
Piperacillin (T-1220), a new semisynthetic penicillin. II. In vitro antimicrobial activity and synergy comparison with carbenicillin and gentamicin
R N Jones, R R Packer, A L Barry, et al.
Page
of 82